Literature DB >> 35689786

Systemic inflammatory markers in relation to cognitive function and measures of brain atrophy: a Mendelian randomization study.

Jiao Luo1,2, Saskia le Cessie3,4, Gerard Jan Blauw5, Claudio Franceschi6, Raymond Noordam5, Diana van Heemst5.   

Abstract

Observational studies have implied associations between multiple cytokines and cognitive decline, anti-inflammatory drugs however did not yield any protective effects on cognitive decline. We aimed to assess the associations of systemic inflammation, as measured by multiple cytokine and growth factor, with cognitive performance and brain atrophy using two-sample Mendelian randomization (MR). Independent genetic instruments (p < 5e - 8 and p < 5e - 6) for 41 systemic inflammatory markers were retrieved from a genome-wide association study conducted in 8293 Finnish participants. Summary statistics for gene-outcome associations were obtained for cognitive performance (N = 257,841) and for brain atrophy measures of cerebral cortical surface area and thickness (N = 51,665) and hippocampal volume (N = 33,536). To rule out the heterogeneity in the cognitive performance, we additionally included three domains: the fluid intelligence score (N = 108,818), prospective memory result (N = 111,099), and reaction time (N = 330,069). Main results were computed by inverse-variance weighting; sensitivity analyses taking pleiotropy and invalid instruments into account were performed by using weighted-median estimator, MR-Egger, and MR PRESSO. After correcting for multiple testing using false discovery rate, only genetically predicted (with p < 5e - 6 threshold) per-SD (standard deviation) higher IL-8 was associated with - 0.103 (- 0.155, - 0.051, padjusted = 0.004) mm3 smaller hippocampal volume and higher intelligence fluid score [β: 0.103 SD (95% CI: 0.042, 0.165), padjusted = 0.041]. Sensitivity analyses generally showed similar results, and no pleiotropic effect, heterogeneity, or possible reverse causation was detected. Our results suggested a possible causal association of high IL-8 levels with better cognitive performance but smaller hippocampal volume among the general healthy population, highlighting the complex role of inflammation in dementia-related phenotypes. Further research is needed to elucidate mechanisms underlying these associations.
© 2022. The Author(s).

Entities:  

Keywords:  Cerebral cortex; Cognitive function; Cytokines; Hippocampal volume; Inflammation

Year:  2022        PMID: 35689786     DOI: 10.1007/s11357-022-00602-7

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  44 in total

1.  Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies.

Authors:  Xue-Ning Shen; Li-Dong Niu; Yan-Jiang Wang; Xi-Peng Cao; Qiang Liu; Lan Tan; Can Zhang; Jin-Tai Yu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-01-10       Impact factor: 10.154

2.  Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.

Authors:  Howard A Fink; Eric Jutkowitz; J Riley McCarten; Laura S Hemmy; Mary Butler; Heather Davila; Edward Ratner; Collin Calvert; Terry R Barclay; Michelle Brasure; Victoria A Nelson; Robert L Kane
Journal:  Ann Intern Med       Date:  2017-12-19       Impact factor: 25.391

3.  Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.

Authors:  Ka Sing P Lai; Celina S Liu; Allison Rau; Krista L Lanctôt; Cristiano A Köhler; Maureen Pakosh; André F Carvalho; Nathan Herrmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-08-09       Impact factor: 10.154

4.  The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis.

Authors:  Alain Koyama; Jacqueline O'Brien; Jennifer Weuve; Deborah Blacker; Andrea L Metti; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-14       Impact factor: 6.053

5.  Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis.

Authors:  Sirwan K L Darweesh; Frank J Wolters; M Arfan Ikram; Frank de Wolf; Daniel Bos; Albert Hofman
Journal:  Alzheimers Dement       Date:  2018-03-29       Impact factor: 21.566

6.  Changes in brain function occur years before the onset of cognitive impairment.

Authors:  Lori L Beason-Held; Joshua O Goh; Yang An; Michael A Kraut; Richard J O'Brien; Luigi Ferrucci; Susan M Resnick
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

7.  Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study.

Authors:  Keenan A Walker; Rebecca F Gottesman; Aozhou Wu; David S Knopman; Alden L Gross; Thomas H Mosley; Elizabeth Selvin; B Gwen Windham
Journal:  Neurology       Date:  2019-02-13       Impact factor: 9.910

Review 8.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

9.  Cognition Is Associated With Peripheral Immune Molecules in Healthy Older Adults: A Cross-Sectional Study.

Authors:  Cláudia Serre-Miranda; Susana Roque; Nadine Correia Santos; Patrício Costa; Nuno Sousa; Joana Almeida Palha; Margarida Correia-Neves
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

Review 10.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

Authors:  Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

View more
  1 in total

1.  Association of mTORC1‑dependent circulating protein levels with cataract formation: a mendelian randomization study.

Authors:  Yingjun Cai; Kangcheng Liu; Pengfei Wu; Ruolan Yuan; Fei He; Jing Zou
Journal:  BMC Genomics       Date:  2022-10-21       Impact factor: 4.547

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.